SHARED CARE PATIENT SURVEY
SHARED CARE PATIENT SURVEY CNETS wants to hear YOUR STORY to help make NET care better. You can share with us by completing the survey linked to this post. [...]
Caring Virtually: A Virtual Care Oncology Patient Study
I am writing to you as the co-Principal Investigator on CaringVirtually, a virtual care oncology patient study, requesting your support in sharing information about this study with your patient [...]
Patient Input – Treatment with Telotristat
TELOTRISTAT is an adjunct to somatostatin analogue therapy for the long-term treatment of carcinoid syndrome to improve symptom control in adult patients with metastatic neuroendocrine tumours.The company who makes telotristat [...]
NET Research Priorities Survey Results
In March CNETS Canada reached out to the patient community through an online, anonymous survey to gather feedback and input on setting the research priorities for CNETS Canada sponsored grants [...]
Patient Input – Treatment with Lutetium-177 (177Lu)-DOTATATE
REQUEST FOR PATIENT INPUT - TREATMENT WITH Lutetium-177 (177Lu)-DOTATATE (trade name Lutathera) Lutetium-177 (177Lu)-DOTATATE (trade name Lutathera), is a peptide receptor radionuclide therapy (PRRT) with radiolabeled somatostatin analogues (peptides). [...]